These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 29300680)

  • 1. Utilization pattern of Haemophilus influenza type b vaccine in eight provinces of China.
    Li Y; Yue C; Wang Y; Zhu X; Martin K; Scherpbier RW; Liu J; Wang Z; Ma Y; Cheng H; Zhang Z; Wang Q; Li H; Xie S; Xiao Q; Wang H; An Z
    Hum Vaccin Immunother; 2018 Apr; 14(4):894-899. PubMed ID: 29300680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of residency and urbanicity on Haemophilus influenzae Type b and pneumococcal immunization in Shanghai Children: a Retrospective Cohort Study.
    Wagner AL; Sun X; Montgomery JP; Huang Z; Boulton ML
    PLoS One; 2014; 9(5):e97800. PubMed ID: 24828814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemophilus influenzae serotype b conjugate vaccine failure in twelve countries with established national childhood immunization programmes.
    Ladhani S; Heath PT; Slack MP; McIntyre PB; Diez-Domingo J; Campos J; Dagan R; Ramsay ME;
    Clin Microbiol Infect; 2010 Jul; 16(7):948-54. PubMed ID: 19889054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lot-to-lot consistency, safety and immunogenicity of 3 lots of Haemophilus influenzae type b conjugate vaccine: results from a phase III randomized, multicenter study in infants.
    Klein NP; Abu-Elyazeed R; Cornish M; Leonardi ML; Weiner LB; Silas PE; Grogg SE; Varman M; Frenck RW; Cheuvart B; Baine Y; Miller JM; Leyssen M; Mesaros N; Roy-Ghanta S
    Vaccine; 2017 Jun; 35(28):3564-3574. PubMed ID: 28536030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody concentration and clinical protection after Hib conjugate vaccination in the United Kingdom.
    Heath PT; Booy R; Azzopardi HJ; Slack MP; Bowen-Morris J; Griffiths H; Ramsay ME; Deeks JJ; Moxon ER
    JAMA; 2000 Nov; 284(18):2334-40. PubMed ID: 11066183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological persistence in 5 y olds previously vaccinated with hexavalent DTPa-HBV-IPV/Hib at 3, 5, and 11 months of age.
    Silfverdal SA; Assudani D; Kuriyakose S; Van Der Meeren O
    Hum Vaccin Immunother; 2014; 10(10):2795-8. PubMed ID: 25483640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modelling the effects of booster dose vaccination schedules and recommendations for public health immunization programs: the case of Haemophilus influenzae serotype b.
    Charania NA; Moghadas SM
    BMC Public Health; 2017 Sep; 17(1):705. PubMed ID: 28903749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity and safety of two doses of catch-up immunization with Haemophilus influenzae type b conjugate vaccine in Indian children living with HIV.
    Arya BK; Bhattacharya SD; Sutcliffe CG; Saha MK; Bhattacharyya S; Niyogi SK; Moss WJ; Panda S; Das RS; Mallick M; Mandal S
    Vaccine; 2016 Apr; 34(19):2267-74. PubMed ID: 26988256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined Haemophilus Influenzae type B-Neisseria meningitidis serogroup C vaccine is immunogenic and well tolerated in preterm infants when coadministered with other routinely recommended vaccines.
    Omeñaca F; Arístegui J; Tejedor JC; Moreno-Perez D; Ruiz-Contreras J; Merino JM; Muro Brussi M; Sánchez-Tamayo T; Castro Fernandez J; Cabanillas L; Peddiraju K; Mesaros N; Miller JM
    Pediatr Infect Dis J; 2011 Nov; 30(11):e216-24. PubMed ID: 21747321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasive disease due to Haemophilus influenzae serotype b ten years after routine vaccination, South Africa, 2003-2009.
    von Gottberg A; Cohen C; Whitelaw A; Chhagan M; Flannery B; Cohen AL; de Gouveia L; Plessis Md; Madhi SA; Klugman KP;
    Vaccine; 2012 Jan; 30(3):565-71. PubMed ID: 22119925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, controlled, blinded study of the safety and immunogenicity of Haemophilus influenzae type b conjugate vaccine injected at different intramuscular sites in Chinese infants.
    Shi N; Luo F; Li L; Zheng D; Zhang Z; Wang Z; Yang L; Liu Z; Ai X; Bai Y; Lu Q
    Hum Vaccin Immunother; 2013 Nov; 9(11):2311-5. PubMed ID: 23842003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in measurement of Haemophilus influenzae serotype b (Hib) vaccination coverage --- National Immunization Survey, United States, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Aug; 59(33):1069-72. PubMed ID: 20798669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Haemophilus influenzae type b vaccination without a booster dose on invasive H influenzae type b disease, nasopharyngeal carriage, and population immunity in Kilifi, Kenya: a 15-year regional surveillance study.
    Hammitt LL; Crane RJ; Karani A; Mutuku A; Morpeth SC; Burbidge P; Goldblatt D; Kamau T; Sharif S; Mturi N; Scott JA
    Lancet Glob Health; 2016 Mar; 4(3):e185-94. PubMed ID: 26853149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity and safety of four different doses of Haemophilus influenzae type b-tetanus toxoid conjugated vaccine, combined with diphtheria-tetanus-pertussis vaccine (DTP-Hib), in Indonesian infants.
    Punjabi NH; Richie EL; Simanjuntak CH; Harjanto SJ; Wangsasaputra F; Arjoso S; Rofiq A; Prijanto M; Julitasari ; Yela U; Herzog C; Cryz SJ
    Vaccine; 2006 Mar; 24(11):1776-85. PubMed ID: 16303216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemophilus influenzae type b (Hib) vaccine: an effective control strategy in India.
    Verma R; Khanna P; Chawla S; Bairwa M; Prinja S; Rajput M
    Hum Vaccin; 2011 Nov; 7(11):1158-60. PubMed ID: 22048118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A nationwide population-based surveillance of invasive Haemophilus influenzae diseases in children after the introduction of the Haemophilus influenzae type b vaccine in Japan.
    Suga S; Ishiwada N; Sasaki Y; Akeda H; Nishi J; Okada K; Fujieda M; Oda M; Asada K; Nakano T; Saitoh A; Hosoya M; Togashi T; Matsuoka M; Kimura K; Shibayama K
    Vaccine; 2018 Sep; 36(38):5678-5684. PubMed ID: 30122645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naturally acquired and conjugate vaccine-induced antibody to Haemophilus influenzae type b (Hib) polysaccharide in Malian children: serological assessment of the Hib immunization program in Mali.
    Hutter J; Pasetti MF; Sanogo D; Tapia MD; Sow SO; Levine MM
    Am J Trop Med Hyg; 2012 Jun; 86(6):1026-31. PubMed ID: 22665612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do we need a booster of Hib vaccine after primary vaccination? A study on anti-Hib seroprevalence in Sweden 5 and 15 years after the introduction of universal Hib vaccination related to notifications of invasive disease.
    Hallander HO; Lepp T; Ljungman M; Netterlid E; Andersson M
    APMIS; 2010 Nov; 118(11):878-87. PubMed ID: 20955461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the effectiveness of Haemophilus influenzae type b conjugate vaccine introduction against radiologically-confirmed hospitalized pneumonia in young children in Ukraine.
    Pilishvili T; Chernyshova L; Bondarenko A; Lapiy F; Sychova I; Cohen A; Flannery B; Hajjeh R
    J Pediatr; 2013 Jul; 163(1 Suppl):S12-8. PubMed ID: 23773588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and safety of a new hexavalent vaccine (DTaP5-IPV-HB-Hib) administered in a mixed primary series schedule with a pentavalent vaccine (DTaP5-IPV-Hib).
    Martinón-Torres F; Boisnard F; Thomas S; Sadorge C; Borrow R;
    Vaccine; 2017 Jun; 35(30):3764-3772. PubMed ID: 28583305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.